T. Y. Kim

433 total citations
9 papers, 126 citations indexed

About

T. Y. Kim is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, T. Y. Kim has authored 9 papers receiving a total of 126 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 7 papers in Pulmonary and Respiratory Medicine and 3 papers in Surgery. Recurrent topics in T. Y. Kim's work include Colorectal Cancer Treatments and Studies (5 papers), Lung Cancer Treatments and Mutations (4 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (3 papers). T. Y. Kim is often cited by papers focused on Colorectal Cancer Treatments and Studies (5 papers), Lung Cancer Treatments and Mutations (4 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (3 papers). T. Y. Kim collaborates with scholars based in South Korea, United States and Malaysia. T. Y. Kim's co-authors include Do‐Youn Oh, Kuhn‐Uk Lee, S.-A. Im, Jung Hoon Kim, Masao Kobayashi, Kwang‐Il Kim, Yoon Sim Yap, Seock‐Ah Im, Gerardo Cornelio and Eui Kyu Chie and has published in prestigious journals such as Journal of Clinical Oncology, British Journal of Cancer and Annals of Oncology.

In The Last Decade

T. Y. Kim

9 papers receiving 121 citations

Peers

T. Y. Kim

ONCOL

PRM

SURGE

MB

HEPAT

Cheng Tzu Yen Brazil

Chengyou Du China

Fengjiao Zhao China

Benjamin Shum United Kingdom

Fumimasa Kitamura Japan

Shijie Wang China

Zuojun Zhen China

Shuaixi Yang China

Jody Corbelli Italy

Cheng Tzu Yen Brazil

T. Y. Kim

39 ×0.5

ONCOL

61 ×0.9

PRM

21 ×0.7

SURGE

36 ×1.2

MB

12 ×0.5

HEPAT

Citations per year, relative to T. Y. Kim T. Y. Kim (= 1×) peers Cheng Tzu Yen

Countries citing papers authored by T. Y. Kim

Since Specialization

Citations

This map shows the geographic impact of T. Y. Kim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by T. Y. Kim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites T. Y. Kim more than expected).

Fields of papers citing papers by T. Y. Kim

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by T. Y. Kim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by T. Y. Kim. The network helps show where T. Y. Kim may publish in the future.

Co-authorship network of co-authors of T. Y. Kim

This figure shows the co-authorship network connecting the top 25 collaborators of T. Y. Kim. A scholar is included among the top collaborators of T. Y. Kim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with T. Y. Kim. T. Y. Kim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

1.

Eom, Keun‐Yong, Eui Kyu Chie, Kwang‐Il Kim, et al.. (2013). Postoperative chemoradiotherapy following pancreaticoduodenectomy. Strahlentherapie und Onkologie. 189(9). 753–758. 6 indexed citations

2.

Yap, Yoon Sim, Gerardo Cornelio, Chonlakiet Khorprasert, et al.. (2012). Brain metastases in Asian HER2-positive breast cancer patients: anti-HER2 treatments and their impact on survival. British Journal of Cancer. 107(7). 1075–1082. 42 indexed citations

3.

Kim, Kwang‐Il, Eui Kyu Chie, Jin‐Young Jang, et al.. (2012). Postoperative chemoradiotherapy for gallbladder cancer. Strahlentherapie und Onkologie. 188(5). 388–394. 19 indexed citations

4.

Lee, Kuhn‐Uk, et al.. (2009). Combination chemotherapy with capecitabine and cisplatin for patients with metastatic hepatocellular carcinoma. Annals of Oncology. 20(8). 1402–1407. 49 indexed citations

5.

Han, Sae‐Won, T. Y. Kim, Keonuk Lee, et al.. (2006). EGFR mutation and intron 1 CA repeat polymorphism as predictive markers of gefitinib responsiveness in non-small cell lung cancer (NSCLC). Journal of Clinical Oncology. 24(18_suppl). 7173–7173. 2 indexed citations

6.

Lee, Keonuk, Do‐Youn Oh, Jung Hee Kim, et al.. (2005). Phase II study of low-dose paclitaxel and cisplatin as second-line therapy in 5-fluorouracil and platinum pretreated gastric cancer. Journal of Clinical Oncology. 23(16_suppl). 4194–4194. 2 indexed citations

7.

Han, Sae‐Won, Seung‐Yong Jeong, Dongwook Kim, et al.. (2005). EGFR mutation and response to chemotherapy in non-small-cell lung cancer (NSCLC) patients. Journal of Clinical Oncology. 23(16_suppl). 7084–7084. 1 indexed citations

8.

Hwang, Pil Gyu, Doo Hyun Chung, Jung Hee Kim, et al.. (2004). Gefitinib monotherapy in previously treated advanced non-small cell lung cancer (NSCLC): An immunohistochemical (IHC) analysis of EGFR and its downstream molecules. Journal of Clinical Oncology. 22(14_suppl). 7096–7096. 2 indexed citations

9.

Kang, Yoon‐Koo, et al.. (1999). A phase II trial of DA-125, a novel anthracycline, in advanced non-small-cell lung cancer. Cancer Chemotherapy and Pharmacology. 44(6). 518–521. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact